197 related articles for article (PubMed ID: 32087727)
1. neoANT-HILL: an integrated tool for identification of potential neoantigens.
Coelho ACMF; Fonseca AL; Martins DL; Lins PBR; da Cunha LM; de Souza SJ
BMC Med Genomics; 2020 Feb; 13(1):30. PubMed ID: 32087727
[TBL] [Abstract][Full Text] [Related]
2. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
[TBL] [Abstract][Full Text] [Related]
3.
Zhang Z; Zhou C; Tang L; Gong Y; Wei Z; Zhang G; Wang F; Liu Q; Yu J
Aging (Albany NY); 2020 Jul; 12(14):14633-14648. PubMed ID: 32697765
[TBL] [Abstract][Full Text] [Related]
4. TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis.
Wu J; Zhao W; Zhou B; Su Z; Gu X; Zhou Z; Chen S
Genomics Proteomics Bioinformatics; 2018 Aug; 16(4):276-282. PubMed ID: 30223042
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive profiling of cancer neoantigens from aberrant RNA splicing.
Wickland DP; McNinch C; Jessen E; Necela B; Shreeder B; Lin Y; Knutson KL; Asmann YW
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38754917
[TBL] [Abstract][Full Text] [Related]
6. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
[TBL] [Abstract][Full Text] [Related]
7. ScanNeo: identifying indel-derived neoantigens using RNA-Seq data.
Wang TY; Wang L; Alam SK; Hoeppner LH; Yang R
Bioinformatics; 2019 Oct; 35(20):4159-4161. PubMed ID: 30887025
[TBL] [Abstract][Full Text] [Related]
8. pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens.
Hundal J; Carreno BM; Petti AA; Linette GP; Griffith OL; Mardis ER; Griffith M
Genome Med; 2016 Jan; 8(1):11. PubMed ID: 26825632
[TBL] [Abstract][Full Text] [Related]
9. TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection.
Zhou Z; Lyu X; Wu J; Yang X; Wu S; Zhou J; Gu X; Su Z; Chen S
R Soc Open Sci; 2017 Apr; 4(4):170050. PubMed ID: 28484631
[TBL] [Abstract][Full Text] [Related]
10. NeoPredPipe: high-throughput neoantigen prediction and recognition potential pipeline.
Schenck RO; Lakatos E; Gatenbee C; Graham TA; Anderson ARA
BMC Bioinformatics; 2019 May; 20(1):264. PubMed ID: 31117948
[TBL] [Abstract][Full Text] [Related]
11. ScanNeo2: a comprehensive workflow for neoantigen detection and immunogenicity prediction from diverse genomic and transcriptomic alterations.
Schäfer RA; Guo Q; Yang R
Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37882750
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets.
Chen C; Zhou Q; Wu R; Li B; Chen Q; Zhang X; Shi C
Biomed Res Int; 2019; 2019():2183510. PubMed ID: 31781598
[TBL] [Abstract][Full Text] [Related]
13. Population-level distribution and putative immunogenicity of cancer neoepitopes.
Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
[TBL] [Abstract][Full Text] [Related]
14. CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens.
Bais P; Namburi S; Gatti DM; Zhang X; Chuang JH
Bioinformatics; 2017 Oct; 33(19):3110-3112. PubMed ID: 28605406
[TBL] [Abstract][Full Text] [Related]
15. Integrated protocol for exitron and exitron-derived neoantigen identification using human RNA-seq data with ScanExitron and ScanNeo.
Wang TY; Yang R
STAR Protoc; 2021 Sep; 2(3):100788. PubMed ID: 34522901
[TBL] [Abstract][Full Text] [Related]
16. TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification.
Tang Y; Wang Y; Wang J; Li M; Peng L; Wei G; Zhang Y; Li J; Gao Z
BMC Bioinformatics; 2020 Nov; 21(1):532. PubMed ID: 33208106
[TBL] [Abstract][Full Text] [Related]
17. DeepHLApan: A Deep Learning Approach for the Prediction of Peptide-HLA Binding and Immunogenicity.
Wu J; Li J; Chen S; Zhou Z
Methods Mol Biol; 2024; 2809():237-244. PubMed ID: 38907901
[TBL] [Abstract][Full Text] [Related]
18. MONET: a database for prediction of neoantigens derived from microsatellite loci.
Deng N; Sinha KM; Vilar E
Front Immunol; 2024; 15():1394593. PubMed ID: 38835776
[TBL] [Abstract][Full Text] [Related]
19. Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy.
Sng CCT; Kallor AA; Simpson BS; Bedran G; Alfaro J; Litchfield K
Front Immunol; 2024; 15():1347542. PubMed ID: 38558815
[TBL] [Abstract][Full Text] [Related]
20. Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information.
Kim S; Kim HS; Kim E; Lee MG; Shin EC; Paik S; Kim S
Ann Oncol; 2018 Apr; 29(4):1030-1036. PubMed ID: 29360924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]